Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation

Critical Care Medicine

Volumn 32, Issue 12, 2004, Pages 2416-2421

  Bakhtiari, Kamran ^a   Meijers, Joost C M ^a   De Jonge, Evert ^a   Levi, Marcel ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Diagnostic test; Disseminated intravascular coagulation; Scoring system

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HEMOSTASIS; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SENSITIVITY ANALYSIS; THROMBOSIS; VALIDATION PROCESS; WAVEFORM;

AGED; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; COHORT STUDIES; CRITICAL CARE; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; GUIDELINES; HEMOSTASIS; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL; SPECTROPHOTOMETRY; SURVIVAL RATE; WHOLE BLOOD COAGULATION TIME;

EID: 10644283860     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000147769.07699.E3     Document Type: Article

References (21)

1. Levi M, ten Cate H: Disseminated intravascular coagulation. N Engl J Med 1999; 341:586-592
2. Levi M, ten Cate H, van der Poll T, et al: Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993; 270:975-979
3. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
4. Levi M, de Jonge E, Meijers J: The diagnosis of disseminated intravascular coagulation. Blood Rev 2002; 16:217-223
5. Boisclair MD, Ireland H, Lane DA: Assessment of hypercoagulable states by measurement of activation fragments and peptides. Blood Reviews 1990; 4:25-40
6. Bick RL: Disseminated intravascular coagulation: Objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic response. Semin Thromb Hemost 1996; 22:69-88
7. Wada H, Gabazza EC, Asakura H, et al: Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): Diagnostic criteria of the International Society of Thrombosis and Hemostasis and of the Japanese Ministry of Health and Welfare for overt DIC. Am J Hematol 2003; 74:17-22
8. Taylor FBJ, Toh CH, Hoots WK, et al: Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86:1327-1330
9. Toh CH, Samis J, Downey C, et al: Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca(++)-dependent complex of C-reactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation. Blood 2002; 100:2522-2529
10. Clauss A: Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens. Acta Haematol 1957; 17:237-246
11. Dhainaut JF, Yan SB, Joyce DE, et al: Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost, In Press
12. Teitel JM, Bauer KA, Lau HK, et al: Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin-antithrombin complex. Blood 1982; 59:1086-1097
13. Moreno R, Vincent JL, Matos R, et al: The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med 1999; 25:686-696
14. Bauer KA, Rosenberg RD: The pathophysiology of the prethrombotic state in humans: Insights gained from studies using markers of hemostatic system activation. Blood 1987; 70:343-350
15. Wheeler AP, Bernard GR: Treating patients with severe sepsis. N Engl J Med 1999; 340:207-214
16. Levi M, de Jonge E, van der Poll T, et al: Advances in the understanding of the pathogenetic pathways of disseminated intravascular coagulation result in more insight in the clinical picture and better management strategies. Semin Thromb Hemost 2001; 27:569-575
17. Warren BL, Eid A, Singer P, et al: Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: A randomized controlled trial. JAMA 2001; 286:1869-1878
18. Abraham E, Reinhart K, Opal S, et al: Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: A randomized controlled trial. JAMA 2003; 290:238-247
19. Toh CH: Transmittance waveform of routine coagulation tests is a sensitive and specific method for diagnosing non-overt disseminated intravascular coagulation. Blood Rev 2002; 16(Suppl 1):S11-S14
20. Nesheim M, Samis J, Walker J, et al: Lipoprotein-complexed C-reactive protein and the biphasic transmittance waveform in critically ill patients. Blood Rev 2002; 16(Suppl 1):S15-S22
21. Levi M, de JE, van dP: Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Crit Care Med 2001; 29(7 Suppl):S90-S94